448 related articles for article (PubMed ID: 17293777)
1. Reduction of experimental diabetic vascular leakage by delivery of angiostatin with a recombinant adeno-associated virus vector.
Shyong MP; Lee FL; Kuo PC; Wu AC; Cheng HC; Chen SL; Tung TH; Tsao YP
Mol Vis; 2007 Jan; 13():133-41. PubMed ID: 17293777
[TBL] [Abstract][Full Text] [Related]
2. Suppression of choroidal neovascularization by adeno-associated virus vector expressing angiostatin.
Lai CC; Wu WC; Chen SL; Xiao X; Tsai TC; Huan SJ; Chen TL; Tsai RJ; Tsao YP
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2401-7. PubMed ID: 11527956
[TBL] [Abstract][Full Text] [Related]
3. Administration of pigment epithelium-derived factor delivered by adeno-associated virus inhibits blood-retinal barrier breakdown in diabetic rats.
Yu H; Chen L; Jiang J
Mol Vis; 2010 Nov; 16():2384-94. PubMed ID: 21139695
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group.
Barber AJ; Antonetti DA; Gardner TW
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3561-8. PubMed ID: 11006253
[TBL] [Abstract][Full Text] [Related]
5. Study of the influence of angiostatin intravitreal injection on vascular leakage in retina and iris of the experimental diabetic rats.
Sima J; Ma J; Zhang SX; Guo J
Yan Ke Xue Bao; 2006 Dec; 22(4):252-8. PubMed ID: 17378159
[TBL] [Abstract][Full Text] [Related]
6. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth.
Duh EJ; Yang HS; Suzuma I; Miyagi M; Youngman E; Mori K; Katai M; Yan L; Suzuma K; West K; Davarya S; Tong P; Gehlbach P; Pearlman J; Crabb JW; Aiello LP; Campochiaro PA; Zack DJ
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):821-9. PubMed ID: 11867604
[TBL] [Abstract][Full Text] [Related]
7. Normalization of retinal vascular permeability in experimental diabetes with genistein.
Nakajima M; Cooney MJ; Tu AH; Chang KY; Cao J; Ando A; An GJ; Melia M; de Juan E
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2110-4. PubMed ID: 11481279
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes.
Gilbert RE; Vranes D; Berka JL; Kelly DJ; Cox A; Wu LL; Stacker SA; Cooper ME
Lab Invest; 1998 Aug; 78(8):1017-27. PubMed ID: 9714188
[TBL] [Abstract][Full Text] [Related]
9. Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats.
Bursell SE; Takagi C; Clermont AC; Takagi H; Mori F; Ishii H; King GL
Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2711-20. PubMed ID: 9418723
[TBL] [Abstract][Full Text] [Related]
10. Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularization.
Raisler BJ; Berns KI; Grant MB; Beliaev D; Hauswirth WW
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8909-14. PubMed ID: 12072560
[TBL] [Abstract][Full Text] [Related]
11. Recombinant adeno-associated virus vector expressing angiostatin inhibits preretinal neovascularization in adult rats.
Lai CC; Wu WC; Chen SL; Sun MH; Xiao X; Ma L; Lin KK; Tsao YP
Ophthalmic Res; 2005; 37(1):50-6. PubMed ID: 15637422
[TBL] [Abstract][Full Text] [Related]
12. Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey.
Witmer AN; Blaauwgeers HG; Weich HA; Alitalo K; Vrensen GF; Schlingemann RO
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):849-57. PubMed ID: 11867607
[TBL] [Abstract][Full Text] [Related]
13. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
Alikacem N; Yoshizawa T; Nelson KD; Wilson CA
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677
[TBL] [Abstract][Full Text] [Related]
14. VEGF-initiated blood-retinal barrier breakdown in early diabetes.
Qaum T; Xu Q; Joussen AM; Clemens MW; Qin W; Miyamoto K; Hassessian H; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2408-13. PubMed ID: 11527957
[TBL] [Abstract][Full Text] [Related]
15. Kallikrein-binding protein levels are reduced in the retinas of streptozotocin-induced diabetic rats.
Hatcher HC; Ma JX; Chao J; Chao L; Ottlecz A
Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):658-64. PubMed ID: 9071220
[TBL] [Abstract][Full Text] [Related]
16. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization.
Mori K; Duh E; Gehlbach P; Ando A; Takahashi K; Pearlman J; Mori K; Yang HS; Zack DJ; Ettyreddy D; Brough DE; Wei LL; Campochiaro PA
J Cell Physiol; 2001 Aug; 188(2):253-63. PubMed ID: 11424092
[TBL] [Abstract][Full Text] [Related]
17. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.
Murata T; Nakagawa K; Khalil A; Ishibashi T; Inomata H; Sueishi K
Lab Invest; 1996 Apr; 74(4):819-25. PubMed ID: 8606491
[TBL] [Abstract][Full Text] [Related]
18. The effect of angiostatin on vascular leakage and VEGF expression in rat retina.
Sima J; Zhang SX; Shao C; Fant J; Ma JX
FEBS Lett; 2004 Apr; 564(1-2):19-23. PubMed ID: 15094037
[TBL] [Abstract][Full Text] [Related]
19. Subconjunctival injection of recombinant AAV-angiostatin ameliorates alkali burn induced corneal angiogenesis.
Cheng HC; Yeh SI; Tsao YP; Kuo PC
Mol Vis; 2007 Dec; 13():2344-52. PubMed ID: 18199977
[TBL] [Abstract][Full Text] [Related]
20. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.
Antonetti DA; Barber AJ; Khin S; Lieth E; Tarbell JM; Gardner TW
Diabetes; 1998 Dec; 47(12):1953-9. PubMed ID: 9836530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
